Bold Solutions
to Challenge AFib

EP Bold Solutions

AFib is a growing crisis in Electrophysiology (EP). This condition affects more than 37 million people.1 We create bold solutions to challenge AFib. This is a suite technology that boldly redefines the EP lab. Clinical support that elevates your practice to meet today’s challenges. It is a partnership to drive impact and grow the EP community.

FROM 37 MILLION TODAY, TO MORE THAN 60 MILLION BY 20501,2

Technology that boldly
redefines the EP lab

Innovate
INNOVATE

Clinical support that elevates your practice to meet today's challenges

Elevate
ELEVATE

Partnerships that drive
impact for the EP community

Impact
IMPACT

ONLY ABBOTT OFFERS A HOLISTIC EP PORTFOLIO

References

  1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19. Erratum in: Int J Stroke. 2020 Jan 28;:1747493020905964. PMID: 31955707.
  2. Morillo, C. A., Banerjee, A., Perel, P., Wood, D., & Jouven, X. (2017). Atrial fibrillation: the current epidemic. Journal of geriatric cardiology: JGC, 14(3), 195–203. http://www.jgc301.com/en/article/doi/10.11909/j.issn.1671-5411.2017.03.011

MAT-2208730 v2.0